Neurotransmitters: How Chemical Messages Affect the Brain
Author: Ukrainian Psychological Hub · Published: October 12, 2026 · Editorial Policy
Neurotransmitters are chemical signaling molecules used by neurons to communicate with other neurons and with target cells such as muscles and glands. They help neural circuits coordinate movement, sensation, attention, learning, motivation, sleep, autonomic regulation, and many other functions. The meaning of a chemical signal depends on where it is released, when it arrives, which receptors are present, and the state of the receiving circuit. This molecular principle is central to neuroscience: the same neurotransmitter can have different effects in different cells and conditions. The National Institute of General Medical Sciences and the neuroscience textbook edited by Purves and colleagues explain the foundational biology.
The familiar claim that one chemical produces one feeling obscures how neurotransmission works. Dopamine participates in movement, learning, and motivation; serotonin influences multiple physiological and behavioral processes; glutamate and GABA support major patterns of excitation and inhibition; and acetylcholine operates in both brain circuits and the neuromuscular junction. These systems act together through thousands of distinct receptor-bearing circuits. A person's psychological state cannot be read from the supposed amount of a single 'happy,' 'stress,' or 'calming' chemical.
What Are Neurotransmitters?
A neurotransmitter is a chemical messenger released by a signaling neuron that acts on receptors in a target cell and changes its activity. Classical textbook criteria emphasize synthesis or availability in the neuron, regulated release during relevant activity, specific receptors capable of reproducing the response, and physiological mechanisms that terminate or regulate its action. Modern neuroscience recognizes diverse exceptions and additional modes of signaling, including gaseous messengers, endocannabinoid signaling, peptide release, extrasynaptic diffusion, and transmission involving glial cells. A substance can have several roles in the body; its status as a neurotransmitter is determined by what it does in a particular signaling system.
Chemical signaling typically occurs at a synapse, the specialized junction where a presynaptic neuron influences a postsynaptic cell. The term neurotransmission describes this communication process, while neuromodulation describes a type of influence that adjusts the responsiveness, gain, plasticity, or behavioral state of a circuit. Neurotransmitters and neuromodulators overlap rather than forming two mutually exclusive chemical inventories. Purves et al. distinguish small-molecule transmitters and neuropeptides, while a 2024 mechanistic review shows why anatomical release sites, diffusion, clearance, and receptor positioning matter.
How Neurotransmitters Work: From Electrical Activity to Chemical Signaling
1. Synthesis, storage, and readiness
Many classical small-molecule transmitters are synthesized from metabolic precursors and loaded into synaptic vesicles by specialized transport proteins. Vesicles are tiny membrane-enclosed compartments concentrated near presynaptic release machinery. Certain neuropeptides are synthesized as precursor proteins in the cell body, processed within the secretory pathway, and transported in dense-core vesicles. Other signals, including nitric oxide and endocannabinoids, may be synthesized and released by distinct mechanisms instead of following the canonical small-vesicle sequence. Neurons therefore possess different molecular toolkits for different chemical messages. Basic Neurochemistry describes how vesicular transport and the proton gradient support transmitter storage.
2. Action potentials, calcium entry, and vesicle fusion
In a common chemical synapse, an action potential reaches a nerve terminal and depolarizes its membrane. Voltage-gated calcium channels open; calcium entering the terminal activates molecular machinery that permits ready vesicles to fuse with the presynaptic membrane. Transmitter molecules are released into the extracellular space. Release probability varies with prior activity, calcium availability, vesicle pool, and the architecture of the release site. Even in a single synapse, transmitter release is probabilistic rather than an automatic one-to-one conversion of every electrical impulse into one fixed chemical dose. See the Society for Neuroscience synapse primer and Purves's account of chemical synapses.
3. Binding to receptors and changing the target cell
Molecules diffuse to receptors on the target membrane, where binding produces a response. Some receptors are ligand-gated ion channels. Their opening or closing changes ion flow and can alter membrane voltage within milliseconds. Other receptors are coupled to intracellular signaling pathways; their effects may develop more slowly and alter ion channels, metabolism, gene regulation, synaptic strength, or the response to other transmitters. The postsynaptic neuron integrates many excitatory and inhibitory inputs before deciding whether and when to fire. Chemical communication therefore transforms incoming activity according to local circuit rules rather than simply copying a message from cell to cell.
4. Clearing, recycling, and controlling the signal
A signal is shaped by how long molecules remain near active receptors. Transporters can move transmitter out of extracellular fluid and into presynaptic cells or glia; enzymes can break down certain transmitters; diffusion distributes molecules away from their release point. Acetylcholinesterase rapidly hydrolyzes acetylcholine at many cholinergic synapses, whereas glutamate is extensively removed by transporters and subsequently recycled through metabolic pathways involving astrocytes. Reuptake and degradation are different mechanisms, and neither one occurs in precisely the same way for every neurotransmitter. Recent review evidence on the glutamate/GABA–glutamine cycle demonstrates the metabolic partnership between neurons and glia.
The Major Types of Neurotransmitters
Chemical classification helps scientists describe how transmitters are synthesized and handled; functional categories describe what a particular signal does in a particular context. Major families include amino acid transmitters, monoamines, acetylcholine, neuropeptides, purines, and several unconventional messenger systems. The number of known signaling molecules changes as researchers refine classification rules, and simple counts differ between scientific and educational resources. NIH's overview and the Neuroscience textbook provide useful starting points; the categories below prioritize mechanism and established roles.
Glutamate: fast excitation, learning, and circuit plasticity
Glutamate is the principal excitatory transmitter in many mammalian central nervous system pathways. Activation of AMPA-type receptors commonly drives rapid excitatory currents; NMDA-type receptors have voltage-dependent properties and are important in many forms of activity-dependent synaptic change. Metabotropic glutamate receptors modulate signaling through slower intracellular pathways. Glutamate is also a central metabolic molecule, so a measurement of total glutamate in tissue is not automatically a measurement of synaptic release. Excess extracellular glutamate can contribute to excitotoxic injury under particular pathological conditions, but ordinary learning is not evidence of 'glutamate toxicity.' Neuronal and astrocytic handling of glutamate is integral to interpreting its function. Evidence review.
GABA and glycine: context-dependent inhibitory signaling
Gamma-aminobutyric acid (GABA) is the main fast inhibitory transmitter across much of the mature brain. GABA-A receptors are ligand-gated ion channels; GABA-B receptors signal through G proteins and often act on a slower time scale. Glycine is another important inhibitory transmitter, particularly in the spinal cord and brainstem. Their effects depend on ion gradients, receptor distribution, developmental stage, and the target circuit. GABA can produce depolarizing responses in some cells or developmental contexts, so describing every GABA action as universal 'calming' misses established physiology. Inhibition organizes timing, selectivity, and coordination; it is an active computational property of neural circuits.
Acetylcholine: muscles, attention, and adaptive signaling
Acetylcholine is released at the neuromuscular junction to activate skeletal muscle and is central to many autonomic nervous system functions. In the brain, cholinergic projections influence attention, arousal, learning, and how sensory information is processed. Nicotinic receptors are ligand-gated ion channels, while muscarinic receptors mediate a variety of slower metabotropic effects. The same molecule thus helps contract a muscle in one anatomical setting and adjust the processing properties of cortical or hippocampal circuits in another. Drugs that interact with cholinergic receptors affect different organs and networks according to their specificity and distribution. Neuroscience overview.
Dopamine: action, reinforcement, and learning
Dopamine participates in movement, reward-related learning, action selection, motivation, and other processes. Its effects depend on the circuits connecting dopaminergic neurons to regions such as the striatum and cortex, and on the receptor families and downstream signaling pathways of the receiving cells. Dopamine is not a direct measure of enjoyment. In particular experiments, brief dopamine responses covary with aspects of prediction error—the discrepancy between expected and observed outcomes—but research also identifies signals related to sensory features, uncertainty, and action. The precise interpretation is model- and circuit-dependent. See Gershman et al. (2024) and Kahnt and Schoenbaum (2025).
Human causal evidence also requires careful interpretation. A 2025 systematic review and meta-analysis of 102 studies reported that pharmacological dopamine manipulations were associated with differences in several reward-learning and response measures, while serotonin manipulations showed a different pattern on punishment-related and discounting measures. The review investigated healthy volunteers and varied experimental interventions; it does not establish a universal chemical explanation for any individual person's motivation or mental health. Familiar everyday examples, including caffeine and dopamine and sugar and dopamine, require similarly precise distinctions between behavioral effects and direct neurochemical measurement.
Serotonin: multiple receptor pathways and broad physiological roles
Serotonin, or 5-hydroxytryptamine (5-HT), is involved in complex regulation of sleep, gastrointestinal function, sensory processing, behavioral flexibility, and affect-related processes. Many serotonin receptor subtypes exist, including multiple G-protein-coupled receptors and the ionotropic 5-HT3 receptor. Their distribution and effects differ considerably. Serotonin produced in the gut does not freely cross the blood-brain barrier, so blood serotonin measurements are not a simple proxy for brain synaptic serotonin activity. A neurotransmitter's involvement in mood-related circuits is not proof that one deficiency causes a psychiatric diagnosis. A systematic umbrella review did not support low serotonin as an established general cause of depression.
Norepinephrine and histamine: arousal and state regulation
Norepinephrine, also called noradrenaline, contributes to arousal, vigilance, attention allocation, stress responding, and autonomic regulation. In the brain, many noradrenergic projections arise in the locus coeruleus and influence distributed targets. Effects depend on receptor type, activation pattern, physiological state, and context; stronger noradrenergic activity does not always improve attention or performance. Histamine-producing neurons, including those arising in the hypothalamus, contribute to wakefulness and other regulatory functions. These systems are often described as modulatory because they change how entire networks respond to incoming information. Review of volume transmission.
Neuropeptides, purines, endocannabinoids, and gaseous messengers
Neuropeptides include endogenous opioids, substance P, neuropeptide Y, and many other signaling molecules. They can shape pain processing, appetite, stress physiology, motivation, and social behavior through receptors that often operate on longer time scales than fast ionotropic transmission. ATP and adenosine also signal through purinergic receptors, linking neuronal activity to cellular energy-related processes. Endocannabinoids are often synthesized on demand and can travel from postsynaptic cells toward presynaptic terminals, changing subsequent transmitter release. Nitric oxide can diffuse locally across membranes as a gaseous signal. Oxytocin is a neuropeptide and hormone with context-dependent physiological and behavioral effects; labeling it a universal 'bonding chemical' is an oversimplification. The classification depends on molecular context and route of action. Purves et al. cover these families.
Excitatory, Inhibitory, and Modulatory: What These Terms Really Mean
Excitatory and inhibitory describe functional effects on a target cell, usually in relation to the probability, timing, or consequences of its electrical activity. In many adult central synapses, glutamate produces excitatory postsynaptic effects and GABA produces inhibitory ones. Yet receptor subtype, membrane voltage, ion gradients, location along a neuron, and circuit state all influence the observed response. A presynaptic neuron can inhibit an inhibitory cell, producing net disinhibition of a downstream pathway. A single molecule cannot be assigned one simple psychological sign such as 'good' or 'bad.'
Neuromodulation refers to signaling that changes the strength, duration, operating mode, or plasticity of neural processing. Dopamine, serotonin, norepinephrine, acetylcholine, peptides, and other molecules can exert modulatory effects. Some act locally at synaptic contacts; others spread through extrasynaptic space, a phenomenon called volume transmission. A 2024 molecular review emphasizes that volume transmission has many mechanistic variations, and a classical distinction between a fast local synapse and a diffuse slow neuromodulator is a useful starting model rather than a universal law.
Receptors Explain Why the Same Chemical Can Have Different Effects
Receptor proteins provide much of the selectivity of chemical communication. Ionotropic receptors directly control membrane channels, often producing rapid electrical changes. Metabotropic receptors engage intracellular signaling systems, which can modify channels, vesicle release, metabolism, and long-term changes in the cell. Even two neurons exposed to the same transmitter may respond differently because they express different receptor subtypes, place them at different cellular locations, or possess different ion gradients and intracellular machinery. Pharmacological selectivity likewise depends on which receptors a compound targets, how strongly it binds, and where the compound reaches.
Presynaptic receptors also regulate signaling. An autoreceptor can respond to a neuron's own released transmitter and provide feedback about subsequent synthesis or release. Heteroreceptors can respond to another cell's transmitter. Receptors can change in number, trafficking, sensitivity, or downstream coupling across development and experience. This adaptability complicates popular explanations that equate the strength of a psychological function with the raw concentration of one substance. Chemical concentration matters, but receptor occupancy, timing, localization, and circuit feedback matter too.
One Neuron, More Than One Chemical Message
Some neurons release more than one transmitter. Two substances may be stored in different vesicle populations or, in certain cases, within the same vesicle. Their releases may depend on different firing patterns, locations, or regulatory machinery, allowing a neuron to send fast and slower signals with partly different consequences. This co-transmission is well established in several animal and cellular preparations; its prevalence and detailed roles across human circuits are more difficult to establish directly. Hnasko and Edwards's review synthesizes the relevant cellular evidence, and modern volume-transmission research shows why transmitter identity alone cannot specify the information encoded by a neuron.
Where in the Brain Do Neurotransmitter Systems Operate?
Neurochemical systems are spatially organized. Glutamate and GABA neurons are widespread, supporting local and long-range connections across multiple regions. Certain modulatory systems arise from relatively concentrated populations and project to distributed targets: midbrain dopamine neurons, brainstem noradrenergic and serotonergic populations, basal forebrain and brainstem cholinergic neurons, and hypothalamic histaminergic neurons are examples. Particular nuclei and pathways matter, but no nucleus exclusively 'owns' happiness, anxiety, desire, sleep, or attention. Psychological functions emerge from patterns of activity, bodily feedback, learned experience, and the coordination of multiple neural populations.
The same transmitter can participate in cortical information processing, subcortical action selection, autonomic regulation, and peripheral signaling. Consequently, statements such as 'dopamine is high' or 'serotonin is low' usually lack the necessary anatomical resolution. Where was the signal measured? During what behavior or time window? In which cell type, projection, receptor population, and physiological context? Scientifically meaningful explanations specify these dimensions instead of treating the entire brain as one chemical container.
Neurotransmitters, Plasticity, Learning, and Behavior
Learning requires coordinated changes across synapses, populations, circuits, and behavior. Transmitters regulate immediate electrical activity and many forms of short- and long-term synaptic change. Repeated patterns of glutamatergic activity can engage molecular processes associated with long-term potentiation and depression in particular preparations. Inhibitory circuits shape which signals gain access to downstream processing. Dopamine and other modulators can influence when particular experiences are retained, which choices are repeated, or how strongly feedback updates expectations. These are interacting mechanisms whose behavioral consequences vary by task and species. Dopamine research reviews and the 2025 human meta-analysis illustrate the importance of studying circuits and behavior together.
A change in synaptic efficacy observed in tissue, a firing response recorded from animal neurons, a PET receptor measure in humans, and improvement on a cognitive task are different observations. Establishing a causal pathway across these levels requires experimental convergence. The neurobiological language of learning should not be used to claim that a single habit, product, emotional experience, or intervention predictably 'rewires dopamine' or permanently changes a neurotransmitter system in every person.
How Do Scientists Measure Neurotransmitters?
Electrophysiology and receptor pharmacology
Patch-clamp recordings and related electrophysiological methods measure electrical properties of cells, including currents produced by activated receptors. Researchers can apply receptor agonists or antagonists, alter transmitter release, and record how synapses respond. The resulting electrical signal gives evidence about a pathway or receptor function but generally does not count all transmitter molecules in an intact human brain. Intracellular and extracellular recordings, optical methods, genetic interventions, and careful controls can strengthen mechanistic inference, particularly in experimental animals or laboratory preparations.
Microdialysis, electrochemical sensors, and fluorescent probes
Microdialysis samples extracellular fluid in a localized tissue region over relatively coarse time intervals and can quantify selected molecules with chemical analysis. Electrochemical techniques such as fast-scan cyclic voltammetry can detect rapid changes for particular electroactive molecules under suitable conditions; anatomical placement, analyte specificity, calibration, and tissue effects constrain interpretation. Genetically encoded fluorescent sensors can report changes in the presence of a transmitter near a sensor's location, often with greater temporal detail, but their signals depend on sensor kinetics, expression, and possible interactions with the biology being measured. Much of the high-resolution circuit evidence comes from animals or invasive research contexts; it cannot be silently generalized to routine human diagnostic tests.
PET and molecular imaging
Positron emission tomography (PET) uses radiolabeled tracers to estimate properties of selected molecular targets or processes, including certain receptors, transporters, and aspects of dopamine synthesis and release. A receptor-binding scan estimates tracer behavior and target availability under a modeling framework; it is not a direct numerical readout of all synaptic dopamine molecules. Challenge designs can infer changes in endogenous transmitter competition under stated assumptions, but receptor density, affinity, blood flow, motion, kinetics, and other variables can affect the results. A review of dopamine PET radiotracers explains the method's strengths and constraints.
Magnetic resonance spectroscopy, fMRI, and EEG
Magnetic resonance spectroscopy (MRS) estimates spectral signals associated with certain tissue metabolites, including glutamate-related compounds and, using specialized protocols, GABA-related signals. Such measures reflect metabolite pools in a relatively large voxel and do not isolate neurotransmitter released at a specific synapse. Functional MRI primarily measures hemodynamic BOLD changes associated with neural activity, rather than concentrations of serotonin or dopamine. Scalp EEG measures voltage fluctuations arising from coordinated neuronal electrical activity, not chemical concentrations. Combining methods can improve interpretation but does not erase what each instrument actually measures.
Blood, saliva, urine, and cerebrospinal fluid
Laboratory measures of molecules or metabolites in blood, saliva, and urine primarily reflect what is present in those samples. Peripheral synthesis, clearance, metabolism, medications, organ function, and blood-brain barrier compartmentalization can make these measurements poor indicators of central synaptic signaling. Cerebrospinal fluid provides access to a compartment closer to the central nervous system but still cannot resolve neurotransmitter activity at individual synapses or identify a psychological disorder on its own. The clinical interpretation of a biomarker must be established for a specific use and population rather than inferred from the name of a neurotransmitter.
What Do Neurotransmitters Tell Us About Mental Health?
Neurochemical systems matter for psychiatry and neurology because they help organize neural function and because medications can act on receptors, transporters, enzymes, and signaling pathways. Neurotransmitter involvement in a treatment mechanism is different from proof that an untreated condition was caused by too much or too little of that transmitter. Disorders are heterogeneous, and symptoms emerge within biological, psychological, developmental, social, and environmental contexts. Group-level drug responses, receptor binding differences, or genetic associations alone rarely identify one specific cause in one individual.
Depression is a useful example. The serotonin umbrella review by Moncrieff and colleagues found that the surveyed evidence did not substantiate a general serotonin-deficiency explanation of depression. This conclusion is about a causal hypothesis, not a trial showing that selective serotonin reuptake inhibitors lack therapeutic benefit. Clinical efficacy, harms, tolerability, and stopping treatment are separate questions assessed through randomized trials, meta-analyses, and guidelines. The site's detailed depression and the brain article examines those mechanisms, clinical boundaries, and diagnostic limitations.
Likewise, dopamine-related alterations may be relevant to specific symptoms, medication actions, and neurological conditions, yet a patient's motivation cannot be reduced to a dopamine meter. GABAergic, glutamatergic, serotonergic, and noradrenergic systems interact with each other, and medications often change downstream activity over time. Neurochemical associations and experimental pharmacology are important evidence about mechanisms; they do not constitute a validated individual diagnosis or demonstrate that self-administered supplements can correct a claimed imbalance. For disorder-specific clinical assessment, treatment decisions should follow established diagnostic procedures and evidence-based care.
Can You Increase, Balance, or Test Your Neurotransmitters?
Sleep, physical activity, food intake, learning, medication, stress, and social experience influence physiology, and some are associated with changes in neurotransmitter signaling in specific experimental contexts. None supplies an easy universal formula for achieving a desirable brain-wide chemical level. A food that contains a precursor is not guaranteed to increase synaptic transmitter release in the brain; transport, metabolism, feedback, and compartmentalization matter. Claims that an online questionnaire, routine saliva panel, or commercial urine test establishes a person's 'brain neurotransmitter balance' require direct validation against clinically meaningful outcomes. Such tests should not be treated as substitutes for medical assessment.
Treatments that target neurotransmission are selected according to an identified condition, benefits and harms established in appropriate patient groups, and individual clinical circumstances. Modifying serotonin, dopamine, acetylcholine, GABA, or glutamate signaling can have effects in several organ systems at once. Changing a dose or stopping a prescribed medication because a simplified neurotransmitter chart says a chemical is deficient or excessive can create avoidable risks. Questions about prescribed medication belong with a qualified clinician or pharmacist who can review symptoms, interactions, and discontinuation considerations.
Common Neurotransmitter Myths
Myth: Dopamine is the pleasure chemical
Dopamine signaling is involved in reinforcement, movement, motivation, and prediction-related information; pleasure is a wider process distributed across multiple neurochemical and neural systems. Even the influential reward-prediction-error interpretation is being refined in response to newer findings about task features and action. Kahnt and Schoenbaum (2025) and Gershman et al. (2024) discuss evidence that exceeds a single pleasure narrative.
Myth: Serotonin is simply the happiness chemical
Serotonin acts through numerous receptor subtypes and participates in gastrointestinal function, sleep, sensory processing, and aspects of behavior. Neither a momentary feeling nor a psychiatric diagnosis can be equated with a global serotonin concentration. The popular one-chemical cause of depression is not established by the umbrella-review evidence.
Myth: Glutamate is always good, and GABA is always calming
Glutamate and GABA are indispensable to normal circuit computation. Their effects depend on receptors, development, ion gradients, firing patterns, and network position. Increasing or decreasing one indiscriminately is not a meaningful general strategy for 'optimizing' the brain. Normal function requires precisely organized activity, clearance, and metabolic recycling rather than an abstract maximum or minimum.
Myth: Each neuron uses exactly one transmitter
Co-transmission occurs in multiple neural systems. A neuron may influence different targets through more than one chemical messenger, and distinct release sites can carry different information. Experimental evidence supports these mechanisms, although detailed mapping in living human brains remains incomplete. Hnasko and Edwards summarize the established physiology.
Myth: A brain scan or blood panel reveals your full neurotransmitter balance
PET estimates particular molecular targets using tracers and models; MRS estimates certain bulk metabolites; fMRI measures hemodynamics; EEG measures electrophysiological activity. Peripheral tests sample other biological compartments. Each result is limited by anatomy, time resolution, specificity, and the validation of its interpretation. No general-purpose measurement supplies a comprehensive, clinically validated picture of an individual's brain chemical signaling.
What Research Has Established and What Remains Uncertain
Established findings include calcium-dependent vesicular release at classical synapses, receptor-dependent changes in target cells, multiple transmitter classes, transporter and enzyme-mediated signal regulation, and strong evidence of neurotransmitter involvement in neural circuit functions. Co-transmission and extrasynaptic neuromodulation are supported by an expanding mechanistic literature. At a more inferential level, researchers investigate exactly how transmitters encode learning signals, how local activity becomes behavioral change, and which interventions produce sustained benefits in individual patients. Current reviews identify unanswered spatial and temporal questions about volume transmission.
A specific transmitter's contribution to human motivation, emotion, or psychiatric symptoms depends on task design, genetic and developmental differences, receptor subtype, brain area, concurrent signaling, medication history, and the measurement technique. Animal optogenetics, invasive recordings, and pharmacological perturbations can reveal causality in those preparations, while human neuroimaging typically provides narrower, model-dependent inferences. The best scientific explanation combines experiments across levels, replication, and explicit attention to alternative mechanisms instead of turning one correlational result into a universal theory of behavior.
Frequently Asked Questions About Neurotransmitters
Are neurotransmitters hormones?
Both are chemical messengers, and some molecules can operate through more than one signaling route. Neurotransmitters typically describe neuronal release affecting target cells, while hormones are released into circulation to act at distant sites. Norepinephrine and oxytocin illustrate why the molecule's role depends on anatomical context and release pathway.
What is the difference between a neurotransmitter and a receptor?
A neurotransmitter is a signaling molecule. A receptor is a protein or protein complex that detects that molecule and converts binding into a cellular response. Receptor type and location are essential to interpreting what the signal actually does.
Do neurotransmitters travel only between neurons?
Neurons also transmit chemical signals to muscle and gland cells, and some transmitters act outside conventional point-to-point synapses. Extracellular diffusion and communication with glia add further complexity. NIGMS explains the basic neuron-to-target-cell framework.
What is the difference between neurotransmitters and neuromodulators?
Neurotransmitter describes a chemical signal used in neural communication. Neuromodulator emphasizes a mode of action that changes the responsiveness or operating state of circuits. Many substances perform both roles depending on release pattern, target, receptor, and time scale.
Can one neurotransmitter be both excitatory and inhibitory?
Yes. Different receptor subtypes and cellular contexts can produce different effects from the same molecule. Even when a particular synapse consistently excites or inhibits one cell, its net impact on a multi-neuron circuit can differ.
How many neurotransmitters are there?
Textbooks and educational sources report different totals because definitions include different classes of neuropeptides and unconventional signals, and the list changes as research advances. The central scientific point is their diversity and receptor specificity, not one fixed universal count. NIGMS and Purves et al. illustrate differing educational classifications.
Can a neurotransmitter imbalance cause anxiety or depression?
Changes in neurotransmission can contribute to mechanisms involved in symptoms or disorders, but 'imbalance' without a specified molecule, circuit, receptor, time scale, and validated measure is scientifically underspecified. Current evidence does not support diagnosing anxiety or depression by assigning one abnormal neurotransmitter level. The published article on anxiety and the brain discusses relevant research without converting group correlations into an individual diagnosis.
Do supplements boost brain neurotransmitters?
Some nutrients are biochemical precursors or cofactors, and deficiencies can have important health effects. That fact alone does not establish that taking more of a supplement raises a specific synaptic signal or improves mood, focus, or memory in a person without a deficiency. Product-specific clinical trials, dose, safety, interactions, and blood-brain barrier biology all matter.
Can neurotransmitters be observed directly in living humans?
Some invasive research methods and molecular imaging approaches can measure limited aspects of neurotransmitter signaling under carefully controlled conditions. Routine whole-brain, synapse-by-synapse chemical monitoring is not available as a standard clinical examination. Every method answers a narrower question than the phrase 'reading brain chemistry' implies.
Conclusion
Neurotransmitters shape neural communication by linking cellular electrical activity to receptor-specific chemical effects. Their biological significance emerges through synthesis, release, receptor binding, reuptake or degradation, co-transmission, and modulation of interacting circuits. Understanding behavior and experience requires specifying these mechanisms and interpreting the measurements that support them. Strong neuroscience connects chemistry with cells, circuits, bodies, and observed behavior while preserving the limits of evidence at each level.
Related Articles
For an in-depth explanation of locus coeruleus signaling, adaptive attention, arousal, and neural responses to stress, read Norepinephrine: Arousal, Attention, and Neural Stress Responses.
References
Andersen, J. V. (2025). The Glutamate/GABA-Glutamine Cycle: Insights, Updates, and Advances. Journal of Neurochemistry, 169(3), e70029. https://pubmed.ncbi.nlm.nih.gov/40066661/.
Gershman, S. J., Assad, J. A., Datta, S. R., et al. (2024). Explaining dopamine through prediction errors and beyond. Nature Neuroscience, 27, 1645–1655. https://doi.org/10.1038/s41593-024-01705-4.
Hnasko, T. S., & Edwards, R. H. (2012). Neurotransmitter corelease: Mechanism and physiological role. Annual Review of Physiology, 74, 225–243. https://doi.org/10.1146/annurev-physiol-020911-153315.
Holz, R. W., & Fisher, S. K. (1999). Synaptic Transmission. In Basic Neurochemistry: Molecular, Cellular and Medical Aspects (6th ed.). NCBI Bookshelf. https://www.ncbi.nlm.nih.gov/books/NBK27911/.
Kahnt, T., & Schoenbaum, G. (2025). The curious case of dopaminergic prediction errors and learning associative information beyond value. Nature Reviews Neuroscience, 26, 169–178. https://doi.org/10.1038/s41583-024-00898-8.
Kelly, D. A. (2022). Sending Information: Synapses and Neurotransmission. BrainFacts / Society for Neuroscience. https://www.brainfacts.org/brain-anatomy-and-function/cells-and-circuits/2022/synapses-and-neurotransmission-113022.
Kilbourn, M. R. (2021). 11C- and 18F-Radiotracers for In Vivo Imaging of the Dopamine System: Past, Present and Future. Biomedicines, 9(2), 108. https://pmc.ncbi.nlm.nih.gov/articles/PMC7912183/.
Mkrtchian, A., Qiu, Z., Abir, Y., et al. (2025). Differential Associations of Dopamine and Serotonin With Reward and Punishment Processes in Humans: A Systematic Review and Meta-Analysis. JAMA Psychiatry, 82(8), 818–829. https://doi.org/10.1001/jamapsychiatry.2025.0839.
Moncrieff, J., Cooper, R. E., Stockmann, T., et al. (2023). The serotonin theory of depression: A systematic umbrella review of the evidence. Molecular Psychiatry, 28, 3243–3256. https://doi.org/10.1038/s41380-022-01661-0.
National Institute of General Medical Sciences. (2024). What Is a Neurotransmitter? National Institutes of Health. https://www.nigms.nih.gov/biobeat/2024/08/what-is-a-neurotransmitter.
Özçete, Ö. D., Banerjee, A., & Kaeser, P. S. (2024). Mechanisms of neuromodulatory volume transmission. Molecular Psychiatry, 29, 3680–3693. https://doi.org/10.1038/s41380-024-02608-3.
Purves, D., Augustine, G. J., Fitzpatrick, D., et al. (Eds.). (2001). Chemical Synapses. In Neuroscience (2nd ed.). Sinauer Associates / NCBI Bookshelf. https://www.ncbi.nlm.nih.gov/books/NBK11009/.
Purves, D., Augustine, G. J., Fitzpatrick, D., et al. (Eds.). (2001). Neurotransmitters. In Neuroscience (2nd ed.). Sinauer Associates / NCBI Bookshelf. https://www.ncbi.nlm.nih.gov/books/NBK10795/.